Women in sub-Saharan Africa who use modern contraceptives are more likely to be tested for HIV than those who do not, according to a study published April 25, 2016 in the open-access journal PLOS ONE by Katherine Center from the University of Arizona and colleagues.
27 April 2016 | Eurekalert Inf Dis
Woman’s Condom achieves WHO/UNFPA prequalification: The Woman’s Condom, a new female condom designed to be easy to use and more acceptable to women and their partners, has been prequalified by the World Health Organization (WHO)/United Nations Population Fund (UNFPA). The approval marks a critical step forward in expanding options for female-initiated dual protection from pregnancy and sexually transmitted infections (STIs), including HIV.
09 March 2016 | PATH
The subject of contraception is a hot topic in faith communities, which made for some exciting discussions at the recent International Conference on Family Planning in Indonesia. The conference heard that contrary to popular belief, many faith-based organisations do support family planning as a process that helps improve people’s quality of life. For the first time, around 80 representatives from different faith groups attending the conference spoke of their commitment to continue informing and educating their communities on family planning. The consensus was that it is consistent with faith values, in order to protect the rights of women, children and families.
05 February 2016 | Key Correspondents
Because Depo-Provera is an important contraceptive choice and because in many parts of the world, it is the only long-acting, discreet option available to women, it is vital to take the issue of a link between HIV and hormonal contraception quite seriously while adding nuance to the discussion.
27 January 2016 | RH Reality Check
Hormones may alter genital tract immunity in a way that makes women more prone to bacterial and viral infections, while disturbances in natural vaginal microbes may also contribute to the association seen in some studies between use of hormonal contraceptives such as Dep-Provera and susceptibility to HIV infection, according to a laboratory study published in the online journal mBio.
03 October 2015 | HIVandHepatitis.com
South Africa’s first national HIV stigma survey has found that 7 percent of HIV-positive women surveyed reported being sterilised against their will. About 40 percent said contraception use had been a pre-requisite to accessing antiretroviral (ARV) treatment, contrary to national policy.
12 June 2015 | Independent Online
Nearly two dozen doctors and scientists have signed off on a citizen petition to the U.S. Food and Drug Administration urging the agency to add language to Pfizer Inc.’s Depo-Provera birth control shot indicating that the shot could increase a woman’s chances of being infected with HIV.
03 June 2015 | Law 360
Thus far, most evidence pertaining to the use of Depo-Provera and the risk of HIV-infection come from observational studies, which can reveal whether two factors are associated with each other, but cannot determine whether one is causing the other to occur. Given this limitation, some scholars are looking to develop a randomised controlled trial, an experimental study that is better at determining cause and effect.
01 May 2015 | Mail & Guardian
Doctors at some public hospitals in South Africa have allegedly coerced dozens of HIV-positive women to undergo sterilisation over the past three decades, rights groups said Thursday.
20 March 2015 | Yahoo News
A newly published study is stirring up questions about the relationship between Depo-Provera, and other progestogen-only injectable contraceptives, and the risk of HIV acquisition among HIV-negative women. The study triggered a wave of headlines and tweets that boiled down the complexities and caveats of this analysis into an oversimplified statement: Depo increases women’s risk of HIV by 40 percent.
14 January 2015 | RH Reality Check